This suggests that Ikaros binding likely regulates transcription of RAB20; (2) Rab20 most likely has oncogenic activity in colorectal cancer [79,80,81], and myelodysplastic syndrome (MDS) [82,83]. Here, RAB20 is linked to myelodysplastic syndrome.